Company / Depreciation & Amortization
LENZ Therapeutics, Inc. Depreciation & Amortization History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$287.0K
FY2025
5-year range
$15.0K / $2.4M
FY2021-FY2025
Trend
+394.8%
vs FY2024
Sector context
#148 of 168
Health Care
What the data says
Depreciation & Amortization changed +395% YoY in FY2025, a notable deviation from the 5-year average annual change of +262%.
Based on SEC 10-K filings.
$287,000 in FY2025 with a 5-year CAGR of +18.9%.
Increased from $15,000 to $287,000 over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -50.4%
- 5-Year CAGR
- +18.9%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 168This company $287.0K Sector average $212.9M
▼
-99.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +18.9%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 394.8% year-over-year.
- Ranks #148 out of 168 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.71 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $287.0K | +394.8% |
| FY2024 | $58.0K | +286.7% |
| FY2023 | $15.0K | -99.4% |
| FY2022 | $2.4M | +220.4% |
| FY2021 | $734.0K | +506.6% |
| FY2020 | $121.0K | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026